Flagship Biosciences expands pharmaceutical tissue analytics services in Colorado

Back to News

Leading provider of tissue analysis services expands with Denver based pathology operation.

Westminster, CO — March 9, 2012 — Flagship Biosciences, a leading provider of tissue analysis for pharmaceutical and medical device development, is expanding their pathology operations to the Denver area. The company provides a full service of tissue analysis for drug and device development, including tissue procurement, tissue preparation and immunohistochemistry, whole slide quantitative computer-based evaluation, with all services overseen by veterinary and medical anatomic pathologists. The company was co-founded by Dr. David Young, who lives in Boulder and was previously Director of Pathology at OSI Pharmaceuticals.

Flagship Biosciences is a pathology CRO that specializes in tissue-based companion diagnostics and histopathology assessment of efficacy and toxicity using brightfield and fluorescent whole slide imaging.

Share this Post: